Where world-changing ideas get their runway
Bridging the gap between technical innovation and cross-functional scientific alignment.
I unblock the technical alignment bottlenecks that stall complex multi-institution drug discovery initiatives — aligning people, data, and decisions so progress stops slipping through the cracks.
Shaped by MIT precision, UCSF structural biology & biochemistry, and Stanford mechanistic pharmacology.
Built for scientific clarity and strategy at scale.
Trusted by a global NIH-funded drug discovery center for pandemic preparedness and venture-backed biotech companies alike as a cross-functional strategy leader and technical narrative architect.
We turn complex science and technical depth into strategic clarity that moves investors, Scientific Advisory Boards, prospective customers, NIAID and granting institutions, and other key high-stakes decision-makers.
"Working with you has been a delight. You are very consistent, results-oriented, and focused on delivering real value to Latch… going above and beyond to find ways to bring us value.
We have worked with a number of consultants and you are undoubtedly the best we’ve worked with."
-Kyle Giffin, COO and co-founder of LatchBio, Forbes “30 Under 30”
Meet Your Strategist: Dr. Veena Thomas
Dr. Veena Thomas is a scientist and strategist who fuses MIT-trained technical precision with forensic strategic insight. Her path began as an Honors Intern at the FBI Academy in Quantico, where she worked with the Forensic Science Research Unit under top-secret security clearance. From that experience, she learned how evidence, persuasion, and stakes intersect at the highest levels. She carried that lesson into her scientific career as an MIT undergrad, UCSF Ph.D., and Stanford postdoc, earning recognition for her strategic acumen with awards including the NSF Graduate Research Fellowship, NIH NRSA postdoctoral grant, and UCSF School of Pharmacy Teaching Assistant of the Year.
As CEO of DrugAbility LLC, Veena designs smarter drug target portfolio strategies for AI-driven drug discovery companies. Today, through Selling The Science, she helps biotech SaaS companies and drug discovery teams translate complex science into persuasive clarity that compels investors, Scientific Advisory Boards, and prospective customers alike.
Trained in scientific rigor, surgically forensic precision, psychological persuasion, and improvisational comedy (Second City Chicago and ComedySportz), her hallmark is the ability to make complex science strategically undeniable—combining depth, adaptability, and presence to guide high-stakes decisions.
For cross-functional technical alignment for multi-institution drug discovery initiatives / consortia — please inquire directly.
Otherwise, select your focus area:
Biotech & Bioinformatics SaaS
Tech & Data
Let’s talk about your next stage of scale.
If you’re ready for organizations to align, investors to wire, and customers to adopt faster — this is your inflection point.
Powered by strategic positioning and technical precision, built to move you from potential to undeniable traction.
